Verification evidence is still being completed.
FUJIFILM Diosynth Biotechnologies Denmark
Hillerod, Denmark
- Verified lead
- Martin Meeson
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- CEO
- 2026 technical specialization
- Biologics Manufacturing, CDMO Services, Process Development, and Commercial Biopharmaceutical Production
- Review cycle
- May 2026
- Full address
- Biotek Alle 1, 3400 Hillerod, Denmark
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official FUJIFILM Diosynth site confirming the Denmark CDMO and manufacturing footprint.
- Editorial note
- FUJIFILM Diosynth Denmark is published because official company materials confirm the current global chief executive and the Hillerod manufacturing footprint as a major Danish CDMO anchor.
Biologics Manufacturing, CDMO Services, Process Development, and Commercial Biopharmaceutical Production
Official CDMO operating-profile disclosure, Official Denmark site footprint, Corporate leadership disclosure
FUJIFILM Diosynth Denmark is published because official company materials confirm the current global chief executive and the Hillerod manufacturing footprint as a major Danish CDMO anchor.
FUJIFILM Diosynth Biotechnologies Denmark runs biopharmaceutical manufacturing, process development, and clinical and commercial cdmo services in Hillerod, Denmark.
- Lead
- Martin Meeson (verified ↗)
- Address
- Biotek Alle 1, 3400 Hillerod, Denmark (source ↗)
- Compliance
- GMP
- Last reviewed
- 21 Mar 2026 (2mo ago)
- Scale
- Large-scale CDMO manufacturing platform
- Capabilities
- Biopharmaceutical Manufacturing · Process Development · Clinical and Commercial CDMO Services
- Founded
- 2011
- Headcount
- 1001-5000
- Company page (open ↗)
Martin Meeson
CEO
Official FUJIFILM Diosynth site and Denmark materials identifying the Hillerod manufacturing campus.
Open sourceLarge-scale CDMO manufacturing platform
Hillerod, Denmark. Biologics Manufacturing, CDMO Services, Process Development, and Commercial Biopharmaceutical Production. Review completed on 21 Mar 2026.
Danish and international biopharmaceutical manufacturing oversight
Official CDMO operating-profile disclosure, Official Denmark site footprint, Corporate leadership disclosure
Biologics Manufacturing, CDMO Services, Process Development, and Commercial Biopharmaceutical Production
FUJIFILM Diosynth Denmark is published because official company materials confirm the current global chief executive and the Hillerod manufacturing footprint as a major Danish CDMO anchor.
FUJIFILM Diosynth Denmark is published because official company materials confirm the current global chief executive and the Hillerod manufacturing footprint as a major Danish CDMO anchor.
Core capabilities
Primary declared technical activities and areas of operating focus.
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Declared infrastructure
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- VERIFIED ACTIVE 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Frequently asked questions
- Where is FUJIFILM Diosynth Biotechnologies Denmark located?
- FUJIFILM Diosynth Biotechnologies Denmark operates from Biotek Alle 1, 3400 Hillerod, Denmark, Hillerod, Denmark.
- Who runs FUJIFILM Diosynth Biotechnologies Denmark?
- FUJIFILM Diosynth Biotechnologies Denmark is led by Martin Meeson, CEO. Verified 21 Mar 2026.
- What does FUJIFILM Diosynth Biotechnologies Denmark do?
- FUJIFILM Diosynth Biotechnologies Denmark runs biopharmaceutical manufacturing, process development, and clinical and commercial cdmo services in Hillerod, Denmark. Core capabilities: Biopharmaceutical Manufacturing, Process Development, Clinical and Commercial CDMO Services.
Related technical briefs
Briefs that name Hillerod as a covered market or city.
